Home Health News FDA Reverses Stance on Leucovorin for Autism By News Health 3 weeks Ago Share on FacebookShare on Twitter (MedPage Today) — The FDA expanded the approval of leucovorin calcium (Wellcovorin) tablets to treat FOLR1-related cerebral folate transport deficiency (CFD-FOLR1), an ultra-rare hereditary disorder, the agency announced Tuesday. Leucovorin is… Source link : https://www.medpagetoday.com/neurology/autism/120245 Author : Publish date : 2026-03-10 21:00:00 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content ChatGPT Flops for Psychotic Prompts; ADHD Drug and Psychosis; Metabolic Psychiatry By News Health April 1, 2026 When Shared Decision-Making Becomes Medical Paternalism By News Health April 1, 2026 Weight-Loss Drug-Biologic Combo Boosts Relief in PsA By News Health April 1, 2026 More Heart Failure Patients Could Benefit From Lung Impedance Monitoring By News Health April 1, 2026 Welsh Ambulance Service announces freeze on newly-qualified paramedic recruitment By News Health April 1, 2026 How dads are bonding over learning to braid hair By News Health April 1, 2026